 RedHill Biopharma Ltd NASDAQ: RDHL has announced a settlement and license agreement with Aurobindo Pharma USA Inc resolving their patent litigation in the U.S. The litigation was related to Aurobindos Abbreviated New Drug Application seeking approval by the FDA to market a generic version of Movantik naloxegol. 